Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 60; no. 11; pp. 2802 - 2805
Main Authors Garciaz, Sylvain, Loschi, Mickael, De Masson, Adèle, Biard, Lucie, Mercier, Mélanie, Tomowiak, Cécile, Delage, Jeremy, Labussiere-Wallet, Hélène, Sibon, David, Cassuto, Ophélie, Borel, Cécile, Cornillon, Jérome, Nimubona, Stanislas, Charbonnier, Amandine, Brice, Pauline, Socié, Gérard, Bouabdallah, Reda, de Latour, Régis Peffault, de Fontbrune, Flore Sicre
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 19.09.2019
Online AccessGet full text
ISSN1042-8194
1029-2403
1029-2403
DOI10.1080/10428194.2019.1599112

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:1042-8194
1029-2403
1029-2403
DOI:10.1080/10428194.2019.1599112